Sort by
Refine Your Search
-
to manuscript preparation. Mentor trainees as opportunities arise and participate in a collaborative, supportive research environment. Required Qualifications PhD (or equivalent doctoral degree) in Neuroscience
-
Haven, CT. Compensation: $68,500 (year 1 Postdoc Associates) + fringe benefits Qualifications: - PhD, MD, or equivalent degree in biology, biomedical sciences, neuroscience, immunology, pharmacology
-
using Yale SPORE lung cancer biobank material Publish first-author papers, present at meetings, and help mentor junior lab members Required qualifications: PhD, MD, or MD/PhD in cell/molecular biology
-
/postdoctoral-compensation and https://postdocs.yale.edu/postdocs/being-a-postdoc-at-yale/benefits-summary . The anticipated start date is August 1, 2026. PhD requirements must be completed by the beginning of
-
Qualifications · PhD or MD/PhD in neuroscience, molecular/cell biology, bioengineering, or a related field. · Demonstrated experience in extracellular vesicle exosome biology and advanced statistical analysis
-
–microbial interactions, and colorectal cancer. The successful candidate will have the opportunity to lead metabolite identification and downstream translational analyses, while also developing independent
-
comparison, and interpretation in a clinical context Preparing manuscripts for publication and presenting findings at national and international conferences Required qualifications PhD in psychology
-
and kinetic modeling. A PhD in biomedical engineering, physics, or a related field is required. However, interested candidates with a strong computational background and interest in getting involved in
-
Postdoctoral Association and Yale Office for Career Strategy. Qualifications Candidates should have or be close to obtaining a PhD in either genetics/genomics, evolutionary biology, computational biology, or a
-
of the applicant. At present, areas of interest to the lab include 1) synthetic enhancers, 2) nucleosome positioning, 3) tumor cell-tumor cell interactions, and 4) disordered regions of transcription factors